story of the week
Intrathecal Administration of Trastuzumab in Patients With HER2+ Breast Cancer With Leptomeningeal Metastasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neuro-Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis
Neuro-oncology 2022 Jul 22;[EPub Ahead of Print], F Oberkampf, M Gutierrez, O Trabelsi Grati, É Le Rhun, O Trédan, I Turbiez, A Kadi, C Dubot, S Taillibert, S Vacher, C BonneauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.